Donna Wilcock, PhD on Sept, 22, 2022.

Donna Wilcock, PhD, of the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs — aducanumab and lecanemab —​ which have been shown to slow the progression of cognitive decline.

Elizabeth Rhodus stretching an exercise band.

A CD player. Lavender-infused lotion. A weighted blanket. A roll of red tape. The last things you’d expect when it comes to Alzheimer’s care. But every item was chosen for a specific purpose: to help care for a person with Alzheimer’s disease and related dementias (ADRD) through their sense of hearing, smell, feel, sight and more.

OB-GYN and former BIRCWH scholar Rachel W. Miller, MD, and her colleague Jill Kolesar, PharmD, are co-directors of the Markey Cancer Center Molecular Tumor Board.

The University of Kentucky’s Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) program has received a five-year grant renewal — making this program over two decades old at the University of Kentucky.

12th Annual Markesbery Symposium on Aging and Dementia

We are pleased to announce the twelfth annual Markesbery Symposium for 2022, named in honor and memory of the late William R. Markesbery, MD, founding Director of the Sanders-Brown Center on Aging and Alzheimer's Disease Research Center. Dr.

Donna Wilcock, PhD on Sept, 22, 2022.

The Alzheimer’s Association welcomes the University of Kentucky’s Donna M. Wilcock, PhD, as the new editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.

Lesley Golden in the lab

I’m a fourth-year graduate student in the department of physiology in Dr. Lance Johnson’s lab. Our lab studies the different isoforms of Apolipoprotein E (ApoE) and their role in Alzheimer’s disease. ApoE4 is the greatest genetic risk factor for late-onset Alzheimer’s disease, but ApoE2 decreases an individual’s risk.

Nick Devanney in the lab

The Johnson lab studies the strongest genetic risk factor for Alzheimer’s disease (AD), apolipoprotein E (APOE). The E4 allele of APOE is carried by more than 25% of the population. A single copy of E4 increases Alzheimer’s risk 3-4 fold compared to the more common E3 allele.

Sanders-Brown team gathered on the stairs.

LEXINGTON, Ky. (Sept. 2, 2022) — A team of researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) has been awarded a $20.5 million grant from the National Institute on Aging (NIA) of the National Institutes of Health (NIH).

Elizabeth Rhodus

As an occupational therapist, Elizabeth Rhodus, PhD, has worked closely with older Kentuckians facing Alzheimer’s disease and related dementias (ADRD). She also has witnessed firsthand how poor health, limited resources, and high poverty rates have served as barriers to proper prevention and treatment.

SBCoA director Linda J. Van Eldik, PhD, on March 14, 2019.

LEXINGTON, Ky. (Aug. 19, 2022) — Linda J. Van Eldik, PhD, director of the University of Kentucky Sanders-Brown Center on Aging, is part of a $1.5 million grant to help further research into a possible treatment for Alzheimer’s disease.

Peter Nelson has dedicated his life, and the past 15 years at the University of Kentucky, to developing research that helps combat neurological diseases.

LEXINGTON, Ky. (Aug. 5, 2022) — Peter T.

Sanders Brown ribbon cutting

LEXINGTON, Ky. (July 25, 2022) — Today, the UK College of Medicine, UK HealthCare, and community leaders celebrated the full opening of the Sanders-Brown Memory Clinic at Turfland. The new, larger clinic replaces the former Sanders-Brown facilities along North Broadway in Lexington.

David Fardo is a 2022-23 University Research Professor.

LEXINGTON, Ky. (July 22, 2022) — David Fardo, PhD, a professor of biostatisticsand the inaugural Stephen W. Wyatt Endowed Professor in the University of Kentucky College of Public Health, is one of 14 University Research Professors for 2022-23.

UK College of Social Work's Allison Gibson, PhD, is working to address a lack of information and services for people with a diagnosis of mild cognitive impairment, which often leads to dementia and Alzheimer's disease.

LEXINGTON, Ky. (July 21, 2022) — In her work with the University of Kentucky Sanders-Brown Center on Aging, UK College of Social Work Associate Professor Allison Gibson, PhD, has noticed an array of responses when people receive a diagnosis of mild cognitive impairment (MCI).

Mark Ebbert and his research assistants on Aug. 5, 2021.

LEXINGTON, Ky. (June 29, 2022) — A recent publication from researchers at the University of Kentucky explains the importance of identifying and understanding how differences between tissues and cells alter gene expression without changing the underlying genetic code.

Woman talking to her grandmother, working at a computer.

LEXINGTON, Ky. (June 23, 2022) — A researcher at the University of Kentucky’s Sanders-Brown Center on Aging is one of several experts in the field who recently discussed the use of two popular screening tests for dementia and Alzheimer’s disease. Frederick A. Schmitt, PhD.

UK researchers Erhard Bieberich and Simone Crivelli have identified new therapeutic targets for Alzheimer’s disease.

LEXINGTON, Ky. (June 15, 2022) — A new University of Kentucky College of Medicine study has identified potential targets to develop a therapy that could prevent Alzheimer’s disease. 

Man sitting with a nurse and his wife.
Lexington Logo

Dementia Friendly Lexington began when a group of concerned community members, including caregivers, persons living with dementia, and representatives from several organizations began to discuss ways Lexington could be more dementia friendly.

GettyImages-1294521570.jpg

LEXINGTON, Ky. (May 2, 2022) — Are you caring for someone with dementia? We invite you to participate in a research study that offers the Harmony at H.O.M.E. (Help Online Modifying the Environment) telehealth program at the University of Kentucky. The program provides training and tools for care partners to assess and modify the home to promote activity engagement and behavior regulation for the person with dementia. This study is led by researchers within UK’s Sanders-Brown Center on Aging.